# Wockhardt clinical trials: 39 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 39 trials with Wockhardt as lead sponsor, 2 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Wockhardt: 39 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/wockhardt

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 39
- Recruiting or not yet: 2
- Read on: November 19, 2026

## Trials

The 25 newest of 39, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 21, 2026 | NCT07885891 | Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia | Wockhardt | Phase 3 | Not yet recruiting | Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP) | 324 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07885891) |
| September 24, 2026 | NCT07840105 | This is a Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ertapenem-zidebactam Versus Ceftazidime-Avibactam... | Wockhardt | Phase 2 | Not yet recruiting | Complicated Urinary Tract Infections(cUTI), Acute Pyelonephritis | 279 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07840105) |
| November 25, 2025 | NCT07247942 | Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion. | Wockhardt | Phase 1 | Completed | Healthy Subjects (HS) | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07247942) |
| February 4, 2025 | NCT06806995 | A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or... | Wockhardt | Phase 1 | Completed | PHA1A | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06806995) |
| December 7, 2022 | NCT05640531 | Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK 771 | Wockhardt | Phase 1 | Completed | Bioavailability | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05640531) |
| July 28, 2021 | NCT04979806 | Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) | Wockhardt | Phase 3 | Completed | Complicated Urinary Tract Infection, Acute Pyelonephritis | 530 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04979806) |
| May 5, 2021 | NCT04874324 | Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Oral WCK 2349 | Wockhardt | Phase 1 | Completed | Pharmacokinetics | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04874324) |
| June 11, 2019 | NCT03981887 | Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous Nafithromycin | Wockhardt | Phase 1 | Completed | Healthy | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03981887) |
| June 7, 2019 | NCT03979859 | Evaluate The Safety, Tolerability and Pharmacokinetics Of Multiple Ascending Oral Doses Of WCK 4873 In Healthy Adult Volunteers | Wockhardt | Phase 1 | Completed | Healthy | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03979859) |
| April 25, 2019 | NCT03926962 | The Safety, Tolerability And Pharmacokinetics Of Single Ascending Doses And The Effect Of Food On Oral WCK 4873 In Healthy Adult Volunteers | Wockhardt | Phase 1 | Completed | Healthy | 67 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03926962) |
| August 14, 2018 | NCT03630094 | Plasma and Intrapulmonary Concentrations Study of WCK 5222 | Wockhardt | Phase 1 | Completed | PHA1A | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03630094) |
| August 14, 2018 | NCT03630081 | Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) | Wockhardt | Phase 3 | Unknown | Complicated Urinary Tract Infection, Acute Pyelonephritis | 1,004 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03630081) |
| August 9, 2018 | NCT03622008 | To Investigate the Multiple Dose Safety, Tolerability and Pharmacokinetics of WCK 4282 (FEP-TAZ) | Wockhardt | Phase 1 | Completed | Antibiotics Causing Adverse Effects in Therapeutic Use | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03622008) |
| June 13, 2018 | NCT03554304 | Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers | Wockhardt | Phase 1 | Completed | QT/QTc Interval in Healthy Volunteers | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03554304) |
| January 19, 2018 | NCT03405064 | Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections... | Wockhardt | Phase 3 | Completed | Acute Bacterial Skin and Skin Structure Infections | 501 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03405064) |
| October 24, 2016 | NCT02942810 | To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment | Wockhardt | Phase 1 | Completed | Renal Impairment | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02942810) |
| September 16, 2016 | NCT02903836 | Phase II Study of Oral Nafithromycin in CABP | Wockhardt | Phase 2 | Completed | Community-Acquired Bacterial Pneumonia (CABP) | 231 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02903836) |
| May 12, 2016 | NCT02770404 | A Phase 1 Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult Subjects | Wockhardt | Phase 1 | Completed | Healthy Volunteers | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02770404) |
| March 16, 2016 | NCT02709382 | A Single-dose Study to Investigate the Pharmacokinetics of Intravenous FEP-TAZ in Patients With Renal Impairment | Wockhardt | Phase 1 | Completed | Renal Impairment | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02709382) |
| March 14, 2016 | NCT02707107 | MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers | Wockhardt | Phase 1 | Completed | Serious Gram-negative Infections | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02707107) |
| February 4, 2016 | NCT02674347 | MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults | Wockhardt | Phase 1 | Completed | Healthy Subjects | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02674347) |
| August 25, 2015 | NCT02532140 | Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime | Wockhardt | Phase 1 | Completed | Healthy | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02532140) |
| May 25, 2015 | NCT02453529 | Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects | Wockhardt | Phase 1 | Completed | Healthy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02453529) |
| October 1, 2014 | NCT02253342 | Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human Subjects | Wockhardt | Phase 1 | Completed | Intrapulmonary Pharmacokinetics of WCK 2349 | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02253342) |
| September 19, 2014 | NCT02244827 | Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment | Wockhardt | Phase 1 | Completed | Hepatic Impairment | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02244827) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 30 |
| Phase 2 | 2 |
| Phase 3 | 7 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 30 |
| Withdrawn | 5 |
| Not yet recruiting | 2 |
| Terminated | 1 |
| Unknown | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Diabetes Mellitus | 5 |
| Diabetes Mellitus, Type 1 | 3 |
| Renal Insufficiency | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Taco restaurants in the United States](https://specstream.ai/data/businesses/taco-restaurants/united-states)
- [Air duct cleaning companies in the United States](https://specstream.ai/data/businesses/air-duct-cleaning-companies/united-states)
- [Brewing supply stores in the United States](https://specstream.ai/data/businesses/brewing-supply-stores/united-states)
- [Disability law firms in the United States](https://specstream.ai/data/businesses/disability-law-firms/united-states)
- [General hospitals in the United States](https://specstream.ai/data/businesses/general-hospitals/united-states)
- [Language schools in the United States](https://specstream.ai/data/businesses/language-schools/united-states)
